Tin tức & Cập nhật

In colorectal cancer, the traditional method for removing the tumour is open surgery. However, the surgical treatment landscape has evolved over the years and transitioned to embrace the utilization of minimally invasive approaches such as laparoscopic or keyhole surgery and the use of robotics.

The use of probiotics leads to a significant reduction in chemotherapy-related diarrhoea, suggesting its potential as supportive care agent in oncology, according to a study.

Exposure to acetaminophen (paracetamol) may contribute to poor outcomes in patients with acute viral hepatitis (AVH)-related acute liver failure (ALF), suggests a study.

In a real-world cohort of patients with highly refractory Crohn’s disease (CD), upadacitinib treatment prompted clinical response in most and steroid-free clinical remission in half, while having an acceptable safety profile.

Among patients with gastric cancer and peritoneal metastasis, treatment with neoadjuvant intraperitoneal–systemic (NIPS) regimen, which consists of intraperitoneal (IP) and intravenous (IV) paclitaxel plus S-1, significantly improved overall survival (OS) compared with IV paclitaxel plus S-1 only (PS regimen), according to the DRAGON-01 trial presented at ASCO GI 2025.

In children and adolescents who have contracted COVID-19, gastrointestinal (GI) tract symptoms may remain for up to 2 years, as reported in a large retrospective study.

New drug applications approved by US FDA as of 1-15 February 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

The attainment of remission in EGPA is durable whether treated with benralizumab for 2 years or switched to benralizumab after 52 weeks of mepolizumab treatment, with additional merits observed among those who switched, as indicated in the OLE of MANDARA